ATRIUM Innovations inc.
⚠️ Moderate Risk
FEI: 3003221709 • Quebec, Quebec • CANADA
FEI Number
3003221709
Location
Quebec, Quebec
Country
CANADAAddress
1405 Du Parc-Technologique Blvd, , Quebec, Quebec, Canada
Moderate Risk
FDA Import Risk Assessment
This firm has a moderate history of FDA import refusals. Some attention may be warranted.
Statistics
Score Breakdown
How is this score calculated?
Proprietary Algorithm
- 40% Violation Severity — AI-assessed (1-10)
- 30% Refusal Volume — Logarithmic scale
- 20% Recency — Decays over 5 years
- 10% Frequency — Refusals per year
© ImportRefusal.com Original Analysis
Violation Summary
UNAPPROVED
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).
NO PROCESS
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that the manufacturer's failure to file a scheduled process demonstrates that the product is not being manufactured under the mandatory provisions of 21 CFR Part 108 and therefore appears to have been manufactured, processed, or packed, under insanitary conditions whereby it may have been rendered injurious to health.
UNSFDIETSP
The article appears to be a dietary supplement or ingredient for which there is inadequate information to provide reasonable assurance that such ingredient does not present a significant or unreasonable risk of illness or injury.
NUTRIT LBL
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be misbranded in that the label or labeling fails to bear the required nutrition information.
LABELING
The article appears in violation of FPLA because of its placement, form and/or contents statement.
FILTHY
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that the article appears to consist in whole or in part of a filthy, putrid, or decomposed substance or be otherwise unfit for food.
LACKS FIRM
The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it appears to be misbranded within the meaning of Section 403(e)(1) of the FD&C Act in that the food is in package form and the label fails to bear the name and place of business of the manufacturer, packer, or distributor.
CSTIC LBLG
The labeling appears to fail to comply with cosmetic labeling requirements of Section 602(a), and/or (b), and/or (c), and as identified by 21 C.F.R. Part 701.
LIST INGRE
The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it appears to be misbranded within the meaning of Section 403(i)(2) of the FD&C Act in that it is fabricated from two or more ingredients and the label fails to bear the common or usual name of each such ingredient and/or the article purports to be a beverage containing vegetable or fruit juice, but does not bear a statement with appropriate prominence on the information panel of the total percentage of such fruit or vegetable juice contained in the food.
NEEDS FCE
It appears the manufacturer is not registered as a low acid canned food or acidified food manufacturer pursuant to 21 CFR 108.25(c)(1) or 108.35(c)(1).
NO LICENSE
The article is subject to refusal of admission under section 801(a)(3) of the Federal Food, Drug, and Cosmetic Act (FD&C Act) because it appears to be a biological product for which a biologics license is not in effect under the Public Health Service Act, Part F, Subpart 1-Biological Products, Section 351(a), and it is not the subject of an Investigational New Drug application that is in effect. Therefore, it appears to be a new drug under 201(p) of the FD&C Act that it is in violation of section 505(a) of the FD&C Act because it lacks a new drug approval and because it is misbranded under section 502(f)(1)of the FD&C Act because it fails to bear adequate directions for use
DIETARYLBL
The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it is a dietary supplement that appears to be misbranded within the meaning of Section 403(s)(2)(B) of the FD&C Act in that the label or labeling fails to identify the product by using the term "dietary supplement", which term may be modified with the name of such an ingredient.
UNSAFE ADD
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to bear or contain an unsafe food additive within the meaning of section 409.
FALSE
The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it appears to be misbranded within the meaning of Section 403(a)(1 ) of the FD&C Act in that the labeling is false or misleading in any particular.
Refusal History
| Date | Product | Violations | Division |
|---|---|---|---|
| 12/20/2017 | 54FCK99HERBALS & BOTANICALS (NOT TEAS), N.E.C. | 83NO PROCESS | Division of Northern Border Imports (DNBI) |
| 12/20/2017 | 54FCL99HERBALS & BOTANICALS (NOT TEAS), N.E.C. | 83NO PROCESS | Division of Northern Border Imports (DNBI) |
| 12/20/2017 | 54FCL99HERBALS & BOTANICALS (NOT TEAS), N.E.C. | 83NO PROCESS | Division of Northern Border Imports (DNBI) |
| 12/20/2017 | 54FCL99HERBALS & BOTANICALS (NOT TEAS), N.E.C. | 83NO PROCESS | Division of Northern Border Imports (DNBI) |
| 12/20/2017 | 54FCL99HERBALS & BOTANICALS (NOT TEAS), N.E.C. | 83NO PROCESS | Division of Northern Border Imports (DNBI) |
| 12/20/2017 | 54FCL99HERBALS & BOTANICALS (NOT TEAS), N.E.C. | 83NO PROCESS | Division of Northern Border Imports (DNBI) |
| 12/20/2017 | 54FCL99HERBALS & BOTANICALS (NOT TEAS), N.E.C. | 83NO PROCESS | Division of Northern Border Imports (DNBI) |
| 4/25/2014 | 20DHE99BERRY JUICE, N.E.C. BERRY JUICE OR CONCENTRATES | New York District Office (NYK-DO) | |
| 6/17/2013 | 54ACL90MULTIPLE VITAMINS (MVI-12 VITAMIN COMBO) (VITAMIN) | New York District Office (NYK-DO) | |
| 1/7/2012 | 53PD99OTHER COSMETIC RAW MATERIALS, N.E.C. | 471CSTIC LBLG | New Orleans District Office (NOL-DO) |
| 1/7/2012 | 66VAL99MISCELLANEOUS PATENT MEDICINES, ETC. | 75UNAPPROVED | New Orleans District Office (NOL-DO) |
| 1/7/2012 | 66VAL99MISCELLANEOUS PATENT MEDICINES, ETC. | 75UNAPPROVED | New Orleans District Office (NOL-DO) |
| 1/7/2012 | 66VAL99MISCELLANEOUS PATENT MEDICINES, ETC. | 75UNAPPROVED | New Orleans District Office (NOL-DO) |
| 1/7/2012 | 66VAL99MISCELLANEOUS PATENT MEDICINES, ETC. | 71NO LICENSE | New Orleans District Office (NOL-DO) |
| 11/15/2010 | 54FCL99HERBALS & BOTANICALS (NOT TEAS), N.E.C. | 260FALSE | New York District Office (NYK-DO) |
| 6/1/2009 | 54ECL29YOHIMBE (HERBAL & BOTANICAL TEAS) | 2120UNSFDIETSP | New York District Office (NYK-DO) |
| 6/1/2009 | 54ECL29YOHIMBE (HERBAL & BOTANICAL TEAS) | 2120UNSFDIETSP | New York District Office (NYK-DO) |
| 6/1/2009 | 41YHY99DIETARY CONVENTIONAL FOODS, N.E.C. | 2120UNSFDIETSP | New York District Office (NYK-DO) |
| 8/25/2008 | 54YCL99VITAMIN, MINERAL, PROTEINS AND UNCONVENTIONAL DIETARY SPECIALITIES FOR HUMANS AND ANIMALS, N.E.C. | 218LIST INGRE | New York District Office (NYK-DO) |
| 7/30/2004 | 54GCK99ANIMAL BY-PRODUCTS AND EXTRACTS, N.E.C. | 75UNAPPROVED | Cincinnati District Office (CIN-DO) |
| 7/30/2004 | 54GCK99ANIMAL BY-PRODUCTS AND EXTRACTS, N.E.C. | 75UNAPPROVED | Cincinnati District Office (CIN-DO) |
| 7/30/2004 | 54GCK99ANIMAL BY-PRODUCTS AND EXTRACTS, N.E.C. | 75UNAPPROVED | Cincinnati District Office (CIN-DO) |
| 7/30/2004 | 54GCK99ANIMAL BY-PRODUCTS AND EXTRACTS, N.E.C. | 75UNAPPROVED | Cincinnati District Office (CIN-DO) |
| 7/30/2004 | 54GCK99ANIMAL BY-PRODUCTS AND EXTRACTS, N.E.C. | 75UNAPPROVED | Cincinnati District Office (CIN-DO) |
| 7/30/2004 | 54GCK99ANIMAL BY-PRODUCTS AND EXTRACTS, N.E.C. | 75UNAPPROVED | Cincinnati District Office (CIN-DO) |
| 11/13/2003 | 54GBZ04SHARK (ANIMAL BY-PRODUCTS AND EXTRACTS) | 249FILTHY | New York District Office (NYK-DO) |
| 6/24/2003 | 54FCK99HERBALS & BOTANICALS (NOT TEAS), N.E.C. | Cincinnati District Office (CIN-DO) | |
| 2/14/2003 | 54GBY04SHARK (ANIMAL BY-PRODUCTS AND EXTRACTS) | 473LABELING | New York District Office (NYK-DO) |
| 1/20/2003 | 54GBK01BOVINE (COW, ETC.) (ANIMAL BY-PRODUCTS AND EXTRACTS) | 249FILTHY | New Orleans District Office (NOL-DO) |
| 1/20/2003 | 54GBK01BOVINE (COW, ETC.) (ANIMAL BY-PRODUCTS AND EXTRACTS) | 238UNSAFE ADD | New Orleans District Office (NOL-DO) |
| 6/20/2002 | 54GAK04SHARK (ANIMAL BY-PRODUCTS AND EXTRACTS) | 482NUTRIT LBL | New York District Office (NYK-DO) |
Frequently Asked Questions
What is ATRIUM Innovations inc.'s FDA import refusal history?
ATRIUM Innovations inc. (FEI: 3003221709) has 31 FDA import refusal record(s) in our database, spanning from 6/20/2002 to 12/20/2017.
What is an FEI number?
FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. ATRIUM Innovations inc.'s FEI number is 3003221709.
What types of violations has ATRIUM Innovations inc. received?
ATRIUM Innovations inc. has been cited for 14 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.
Where does this information about ATRIUM Innovations inc. come from?
All FDA import refusal data for ATRIUM Innovations inc. is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.
Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.